Safety of Fresolimumab in the Treatment of Osteogenesis Imperfecta
Condition(s):Osteogenesis ImperfectaLast Updated:July 6, 2022Completed
Hide Studies Not Open or Pending
Condition(s):Osteogenesis ImperfectaLast Updated:July 6, 2022Completed
Condition(s):Orthopedic Disorder; Hemodynamic InstabilityLast Updated:March 29, 2023Recruiting
Condition(s):Knee DiseaseLast Updated:February 16, 2023Not yet recruiting
Condition(s):Stroke; SpasticityLast Updated:November 5, 2015Completed
Condition(s):Uterine Cervical NeoplasmsLast Updated:September 9, 2015Terminated
Condition(s):Jaw, EdentulousLast Updated:July 16, 2014Completed
Condition(s):SarcopeniaLast Updated:May 4, 2017Completed
Condition(s):Image Changes of Lumbar Fusion; Bone Turnover Markers; Bone Mineral DensityLast Updated:March 8, 2011Unknown status
Condition(s):Rehabilitation After Ankle InjuriesLast Updated:November 18, 2019Completed
Condition(s):Postoperative BleedingLast Updated:January 17, 2024Not yet recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.